Partners in Investing

Global stocks and bonds are both expensive. No wonder investors are scouring the earth for attractively priced assets and alpha opportunities. We believe Japan Value and Small Cap Value stocks offer both – a compelling beta opportunity with room for active investors to add value.

Read our latest GMO Insights and learn more about GMO’s Usonian Japan Value Strategy.

Despite the common assumption that Growth stocks are longer duration than Value, this analysis shows that their durations are much closer than most realize. We expect Value to outperform the market over the next few years, and that belief neither assumes nor requires any particular moves in interest rates.

Read our latest White Paper and learn more about GMO’s Equity Dislocation Strategy, designed to profit from the current Growth stock bubble.

GMO Resources Fund and GMO Emerging Country Debt Fund have won U.S. 2021 Refinitiv Lipper Fund Awards, awarded to Funds with consistently strong risk-adjusted three-, five-, and ten-year performance. To view more information about the Awards, click here.

Click for more information on these GMO Funds, including risks and the prospectus: GMO Resources Fund and GMO Emerging Country Debt Fund.

GMO’s Climate Change Strategy gained an impressive almost 43% in 2020, net of fees. We’ve delivered strong returns since our Strategy’s inception in 2017, and this long-term secular growth story is just gaining traction. We’re still in the very early days of the climate fight, and we continue to find compelling investment opportunities where the market isn’t pricing in reasonable growth expectations.

Read the Climate Change Strategy 2020 year-end letter for more details.

In his latest Viewpoints piece, Jeremy Grantham warns that the market is now checking off all the touchy-feely characteristics of a major bubble. Given his experience as a historian of markets, we would be wise to listen.

Click here to read the full article.

GMO’s Quality Strategy looks to build an equity portfolio of the highest quality companies globally that investors can hold over the long term through both up and down markets. Our approach leverages the pioneering work GMO has done since the 1980s in measuring quality characteristics.

Learn more about our Quality Strategy, now available via an Australian Investment Trust.